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UPR signaling pathwaysThe unfolded protein response (UPR) pathways have been implicated in the development of hepatic insulin
resistance during high fructose (HFru) feeding. The present study investigated their roles in initiating impaired
insulin signaling transduction in the liver induced by HFru feeding in mice. HFru feeding resulted in hepatic
steatosis, increased de novo lipogenesis and activation of two arms of the UPR pathways (IRE1/XBP1 and PERK/
eIF2α) in similar patterns from 3 days to 8 weeks. In order to identify the earliest trigger of impaired insulin
signaling in the liver, we fed mice a HFru diet for one day and revealed that only the IRE1 branch was
activated (by 2-fold) and insulin-mediated Akt phosphorylation was blunted (~25%) in the liver. There were
signiﬁcant increases in phosphorylation of JNK (~50%) and IRS at serine site (~50%), protein content of ACC
and FAS (up to 2.5-fold) and triglyceride level (2-fold) in liver (but not in muscle or fat). Blocking IRE1 activity
abolished increases in JNK activity, IRS serine phosphorylation and protected insulin-stimulated Akt
phosphorylation without altering hepatic steatosis or PKCε activity, a key link between lipids and insulin resis-
tance. Our ﬁndings together suggest that activation of IRE1–JNK pathway is a key linker of impaired hepatic in-
sulin signaling transduction induced by HFru feeding.
© 2014 Published by Elsevier B.V.1. Introduction
Type 2 diabetes is closely associatedwith themetabolic syndrome, a
cluster of metabolic disorders including insulin resistance, dys-
lipidaemia, hyperinsulinaemia, central obesity, etc. [1]. While insulin
resistance is one of the fundamental disorders of type 2 diabetes, it is
clear now that dietary nutrients play an important role in the current
prevalence of the metabolic syndrome largely due to their effects on
lipid metabolism in various sites of the body. Apart from the well-
recognized inﬂuence of dietary fat, over-consumption of carbohydrates,
particularly fructose, is increasingly recognized as another important
nutritional factor for obesity [2]. For example, the consumption
of fructose has increased in parallel with the increasing prevalence of
obesity in the past three decades [3].cylglycerol;PKCε, proteinkinase
rotein response; IRE1, inositol-
e;ATF6, activating transcription
ry element-binding protein 1c;
D1, stearoyl-CoA desaturase 1;
on initiation factor 2α; CHOP, C/
DCA, Tauroursodeoxycholic acid
y for Diabetes Group, Health
es, RMIT University, PO Box 71,
9; fax: +61 3 9925 7178.Unlike dietary fat or glucose, dietary fructose is almost entirely
metabolized in the liver in its ﬁrst pass [4] such that the metabolic
effects of fructose largely originate from its primary effects in the liver.
There is increasing evidence to indicate that consumption of diets high
in fructose results in increased de novo lipogenesis (DNL), ectopic lipid
accumulation, insulin resistance, and obesity in animals [5–8], as well
as in humans [9–12]. In line with this, we [13] and others [14] have de-
tected increased DNL, ectopic lipid accumulation along with activated
UPR signaling and impaired insulin sensitivity in the liver of mice fed
an HFru diet for one week. This supports the role of the liver being a
responsive organ that is capable of metabolizing fructose and such
metabolism can rapidly lead to the development of insulin resistance.
Although the cause of hepatic insulin resistance can bemultifactorial
[1], excess lipid accumulation from DNL during HFru feeding is
suggested to be involved [6,8]. For example, accumulation of diacylglyc-
erols (DAGs) has been shown to activate protein kinase C epsilon
(PKCε) in the liver [15]. Activation of PKCε can phosphorylate insulin re-
ceptor or insulin receptor substrate (IRS) at the serine or threonine sites,
which subsequently interferes with insulin signaling transduction by
inhibiting insulin's ability to phosphorylate the tyrosine residues [16].
However, it has been shown that hepatic steatosis including DAG
accumulation may occur independently of hepatic insulin resistance
when PKC is not activated [17]. Apart from the DAG–PKC mechanism
of hepatic insulin resistance, additional factors may be involved for the
development of insulin resistance in the liver. For example, the unfolded
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pathogenesis of hepatic insulin resistance [1].
The UPR consists of a network of signaling pathways emanating
from three leading transducers, namely the inositol-requiring protein
1 (IRE1), protein kinase RNA-like ER kinase (PERK) and activating
transcription factor 6 (ATF6). Activation of these pathways is meant to
restore cellular homeostasis and promote the adaptation to nutrient
ﬂuctuations [18]. However, prolonged activation of UPR has been
shown to cause insulin resistance, particularly in tissues with high se-
cretory demand such as the liver [19,20]. In the liver, activation of UPR
signalingmediated by IRE1 is postulated to interferewith insulin recep-
tor signal transduction via the direct activation of JNK [21]. Interestingly,
activation of IRE1 has been shown to promote DNL [14], whichmay also
lead to lipid accumulation as well as the activation of PKCε. However, it
still remains unclear the respective implication of these cellular events
at the onset of hepatic insulin resistance induced by HFru feeding.
The present study sought to investigate the changes of DNL and UPR
signaling and to identify the initiatingmechanism for hepatic insulin re-
sistance in response to acute HFru feeding. Our ﬁndings demonstrated
that enhanced hepatic DNL and UPR signaling are detectable as early
as 3 days, which were maintained throughout the course of HFru feed-
ing for 8 weeks. Acute HFru feeding was able to impair hepatic insulin
signaling along with promoting DNL and the activation of only the
IRE1 branch of UPR signaling pathway. Inhibition of IRE1 results in an
attenuation of JNK-mediated serine phosphorylation of IRS, preserva-
tion of hepatic insulin signaling and decreased hepatic DNL, despite
marked steatosis. These ﬁndings suggest the activation of IRE1/JNK is
a predominant trigger at the onset of hepatic insulin resistance induced
by HFru feeding.
2. Material and methods
2.1. Animal studies
Male C57BL/6J mice (12 weeks old) from the Animal Resources
Centre (Perth, Australia) were kept at 22 ± 1 °C on a 12 h light/dark
cycle. After 2 weeks of acclimatization, mice were fed for 1 day, 3
days, 1 week or 8 weeks with either normal chow diet (70% calories
from starch, ~10% calories from fat, and ~20% calories from protein;
Gordon's Specialty Stock Feeds, Yanderra, Australia) or high fructose2
(HFru; containing 35% fructose, 35% starch, ~10% fat and ~20% protein)
as described in our previous studies [13]. HFru diet was provided to the
mice from 6 pm to 2 pm (20 h) on the following day when they were
sacriﬁced. The chemical chaperone TUDCA (Sigma Aldrich Pty Ltd,
Australia) was applied by i.p. injection (300 mg kg−1 body weight)
4 h prior to HFru feeding [6,13,22]. The betulin-treated animals were
ﬁrst fed a chow diet mixed with betulin (30 mg kg−1 body weight)
for 1 week and then fed an HFru diet mixed with betulin (30 mg kg−1
body weight) for 20 h. All experiments were approved by the Animal
Ethics Committee of RMIT University.
Bodyweight and food intakeweremeasured before and after exper-
iments. After one day feeding, the mice were fasted for 4 h before the
collection of plasma samples for the measurement of insulin levels by
radioimmunoassay (Linco/Milipore, Billerica, MA) [5,6,23] and glucose
levels using a glucometer (AccuCheck II; Roche, Australia). Tissues of in-
terest were collected and freeze-clamped immediately for subsequent
analyses. Glucose tolerance test (GTT; 2 g kg−1 BW, i.p.) was conducted
in a separate group of mice following a 4 h fasting and blood glucose
levels were measured at 0, 15, 30, 60 and 90 min using a glucometer
(AccuCheck II; Roche, Australia). The area under curve (AUC)was calcu-
lated to estimate glucose intolerance. For the assessment of insulin sig-
naling in the liver, 5–7 hour-fasted mice were injected with insulin2 Diet components (g/kg): Casein: 170; Fructose: 296; Cornstarch: 296; Mineral Mix
(Homemade): 45; Trace Minerals (ICN): 13; BRAN: 34; METHIONINE: 2; GELATINE: 13;
Choline Bitartate: 4; Safﬂower Oil: 5; Lard: 32; AIN Vitamins: 8; Water: 85.(2 U kg−1 BW, i.p.) 20min prior to tissue collection [6,13]. Insulin toler-
ance test (ITT; 0.75 U kg−1 BW, i.p.) was performed in a separate group
of mice and blood glucose levels were measured at 0, 15, 30, 60 and
90 min using a glucometer (AccuCheck II; Roche, Australia). The re-
versed area under curve (AUC)was calculated to estimate glucose intol-
erance. Tissue collection was performed on mice fed an HFru diet for 3
days, 1 week and 8 weeks after 4 h of fasting.
2.2. Measurement of triglyceride levels
Plasma and tissue levels of triglyceride were measured using a
Peridochrom triglyceride GPO-PAP kit (Roche Diagnostics) as described
in our previous studies [6,22]. Liver tissue was homogenized with a
glass homogenizer in chloroform/methanol (2:1, v/v) solution and sub-
jected to an overnight lipid extraction with vigorous mixing. 0.6% (v/v)
NaCl was then added to the homogenate before centrifugation at
2000 rpm for 10 min for phase separation. The lower organic phase
was then transferred into a fresh glass tube and dried under N2 at 45 °C.
The dried pellet was dissolved in ethanol immediately prior to assay.
2.3. Western blotting
Liver, quadricepsmuscle and epididymal fat samples were homoge-
nized in ice-cold lysis buffer at pH 7.5 supplemented with protease in-
hibitor cocktail and phosphatase inhibitor cocktail (Sigma Aldrich Pty
Ltd, Australia) as described previously [6,24]. Cellular fractionation
was performed using sucrose gradient and differential centrifugations
as described by Cantley et al. [25]. Protein samples were then separated
using SDS-PAGE. Insulin signal transductionwas examined using specif-
ic antibodies against phosphorylated (Ser307) IRS1 (Cell Signaling,
USA), total and phosphorylated (Ser473) Akt (Cell Signaling, USA),
total PKCε (Santa Cruz, USA). Key lipogenic enzyme levels were deter-
mined using speciﬁc antibodies including sterol regulatory element-
binding protein 1c (SREBP-1c, Santa Cruz, USA), acetyl-CoA carboxylase
(ACC, Cell Signaling, USA), fatty acid synthase (FAS, Cell Signaling, USA),
stearoyl-CoA desaturase 1 (SCD1, Cell signaling, USA). ER stress-
activated pathways were examined using phosphorylated (Ser724)
inositol-requiring kinase 1 (IRE1, Abcam, USA), X-box binding protein
1 (XBP1, Santa Cruz, USA), phosphorylated (Ser51) eukaryotic transla-
tion initiation factor 2α (eIF2α, Cell signaling, USA), C/EBP homologous
protein (CHOP, Santa Cruz, USA) activating transcription factor 6 α
(ATF6α, Santa Cruz, USA), total and phosphorylated (Thr183/Tyr185)
c-Jun N-terminal kinase (JNK, Cell Signaling, USA), total and phosphor-
ylated (Ser63) c-Jun (Cell Signaling, USA) and phosphorylated mTOR
(Cell Signaling, USA). Immunolabelled protein bands were visualized
by enhanced chemiluminescence and quantiﬁed by densitometry
using BioRad ImageLab software (Bio-Rad Laboratories Inc., USA).
2.4. Statistical analyses
Data are presented asmeans±SE. One-way analysis of variancewas
used for comparison of relevant groups. When signiﬁcant variations
were found, the Tukey–Kramer multiple comparisons test was applied.
Differences at p b 0.05 were considered to be statistically signiﬁcant.
3. Results
3.1. Time course of hepatic DNL and UPR signaling induced by HFru feeding
We ﬁrst examined the expression of key proteins of UPR and DNL in
the liver in relation to changes in glucose tolerance over a range of dif-
ferent feeding periods. Mice fed an HFru diet displayed greater caloric
intake starting at day 3 (p b 0.05 vs. CH) andmanifestedwith glucose in-
tolerance fromday7 as evidenced by the greater area under curve (AUC,
p b 0.05 vs. CH, Table 1). As shown in Fig. 1, HFru feeding also resulted in
the activation of two UPR signaling pathways as indicated by signiﬁcant
Table 1
Changes in metabolic parameters of HFru-fed mice over time.
CH HFru
Body mass (g)
Day 0 26.5 ± 0.5 26.9 ± 0.4
Day 1 27.1 ± 0.4 27.4 ± 0.4
Day 3 26.5 ± 0.6 27.0 ± 0.3
Week 1 26.6 ± 0.4 26.9 ± 0.4
Week 8 27.1 ± 0.6 27.2 ± 0.5
Day 1 12.6 ± 1.9 14.0 ± 1.3
Day 3 10.1 ± 0.5 15.6 ± 0.6 *
Week 1 11.8 ± 0.3 18.4 ± 0.9 **
Week 8 14.8 ± 0.4 18.4 ± 0.8 *
Blood glucose (mM)
Day 1 9.2 ± 0.2 9.2 ± 0.4
Day 3 9.3 ± 0.9 9.0 ± 0.5
Week 1 8.4 ± 0.3 9.5 ± 0.2 **
Week 8 9.2 ± 0.2 11.7 ± 0.6 *
Plasma insulin (pg/ml)
Day 1 1267 ± 131 1841 ± 244 **
Day 3 1345 ± 150 1474 ± 146
Week 1 NA NA
Week 8 1276 ± 116 1450 ± 174
AUC
Day 1 1136 ± 62 953 ± 76
Day 3 1044 ± 48 1098 ± 73
Week 1 1046 ± 32 1256 ± 986 *
Week 8 1020 ± 39 1394 ± 70 **
Male C57BL/6J mice were fed either a chow (CH) or high fructose (HFru) diet for a period
of up to 8 weeks. The calculation of caloric intakewas based on food intake (3.11 kcal/g for
CH diet and 3.569 kcal/g for HFru diet). AUC stands for the area under curve for glucose
tolerance tests. Data are means ± SE of 8–10 mice per group. * p b 0.05, ** p b 0.01 vs
CH-fed mice.
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fold, both p b 0.05). Concomitant to the induction of UPR, the expression
of ACC and FAS, which catalyze the formation of malonyl-CoA and long
chain fatty acids, respectively, were markedly elevated 3 days after the
commencement of HFru feeding (5-folds, both p b 0.01). These dataFig. 1. Time course of hepatic UPR and DNL induced by HFru feeding. Male C57BJ/6J mice (10–
collected after 3 days, 1 week and 8 weeks and immunoblotted for key markers of UPR signal
p b 0.01 compared with the baseline (Day 0). Data are mean ± SE of 6–9 mice per group.indicate that both activations of UPR signaling and the elevated DNL
have reached their maximal levels within 3 days and these changes
are maintained to week 8.
3.2. One day of HFru diet feeding stimulated DNL and lipid accumulation in
the liver but not in muscle or adipose tissue
As both DNL and UPR signaling were induced in parallel by HFru
feeding from 3 days onwards, we next examined the effect of one day
of HFru diet feeding in an attempt to identify which of these cellular
events was triggered earlier. One day feeding of HFru was able to in-
crease the expression of key regulators of DNL in the liver, namely
ACC (2.3-fold), FAS (2.3-fold), mSREBP-1c (1.5-fold) and SCD1 (2.5-
fold, all p b 0.05 vs. CH, Fig. 2A). Consistentwith this, hepatic TG content
was also increased by 2.1-fold (p b 0.01 vs. CH, Fig. 2A right hand panel).
In contrast, no signiﬁcant differenceswere detected for any of these key
regulators for DNL in skeletal muscle (Fig. 2B) and white adipose tissue
(Fig. 2C). Accordingly, the content of TG remained unaltered in skeletal
muscle following one day feeding of HFru (Fig. 2B). These results sug-
gest that one day of HFru diet feeding is sufﬁcient to trigger DNL and
such effect is conﬁned to the liver.
3.3. One day of HFru diet feeding activated the IRE1 and XBP1 splicing in
the liver
As the PERK and IRE signaling arms (but not the ATF6 arm) of the
UPR pathways were both activated after 3 days HFru feeding, we next
examined whether both or only one of these two arms of UPR may be
activated in the liver following one day of HFru diet feeding. As shown
in Fig. 3A, the p-IRE1 and its downstream effector spliced XBP1
(sXBP1) were signiﬁcantly augmented following one day of HFru diet
feeding (2 to 2.5 fold, respectively, both p b 0.01 vs. CH). However,
no signiﬁcant differences were found in the phosphorylation of eIF2α
(p-eIF2α) or the expression CHOP, a downstream protein of the PERK
branch [18]. Similarly, the maturation of ATF6 in the liver remained12 weeks old) were fed a high fructose (HFru) diet for up to 8 weeks. Liver tissues were
ing: phosphorylated-IRE1 and -eIF2α and fatty acid synthesis: ACC and FAS. * p b 0.05; **
Fig. 2. Hepatic DNL and lipid accumulation induced by one day of HFru diet feeding. Mice were exposed for one day of HFru diet feeding. The expression of lipogenic enzyme: ACC, FAS,
matured SREBP-1c and SCD1were determined by immunoblotting ofwhole cell lysate from liver (A), skeletalmuscle (B) and epididymalwhite adipose tissue (C). Representative blots are
shown. Tissue triglyceride (TG) content was determined following 4 h of fasting. Data are mean± SE of 6–8 mice per group. * p b 0.05 compared with CH; ** p b 0.01 compared with CH.
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lack of changes in DNL in skeletal muscle and white adipose tissue, no
signiﬁcant differences were found in any of the measured UPR protein
markers in these tissues (Fig. 3B, C) compared to CH-fed mice. These
data indicate that one day of HFru diet feeding is able to trigger the
activation of speciﬁc UPR signaling in the liver involving the IRE1 arm.
3.4. One day of HFru diet feeding impaired hepatic insulin
signal transduction
We next questioned whether insulin signal transduction might be
affected by the one day of HFru diet feeding. This was associated with
an increased activity of JNK, as evidenced by the increased phosphoryla-
tion of JNK (p-JNK, 1.6-fold, p b 0.05 vs CH) and its downstream effector
c-Jun (p-c-Jun, 1.5-fold, p b 0.05 vs. CH). Consistent with enhanced JNK
activation,we also observed a 50% increase in serine phosphorylation of
IRS (p-IRS, p b 0.05 vs. CH, Fig. 4A) in the liver. As expected, the insulin-
stimulated phosphorylation of Akt (p-Akt) was markedly reduced by
30% in the liver (p b 0.05 vs. CH insulin stimulated) following one day
of HFru diet feeding. Consistently, the phosphorylation of mTOR [26]
and GSK3β [27], downstream targets of Akt, were signiﬁcantly reduced
in HFru-fed mice upon insulin stimulation (Suppl. Figs. 1B and 2). Inaddition, HFru-fed mice showed insulin intolerance as indicated by de-
creased reversed-AUC in ITT (Suppl. Fig. 1A). No detectable defects in
the insulin-stimulated phosphorylation of Akt were found in response
to one day of HFru diet feeding in skeletalmuscle andwhite adipose tis-
sue (Fig. 4B and C). These results indicate that HFru diet is sufﬁcient to
impair hepatic insulin sensitivity and this impairment is closely corre-
lated with the activation of IRE1 pathway.
3.5. Inhibition of IRE1 activity attenuated hepatic DNL induced by one day
of HFru diet feeding
To investigate the relationship between the activation of the IRE1
branch upon HFru feeding and the concomitant increase in DNL and
the impairment of insulin signaling transduction, we next examined
whether dampening the activation of IRE1with the chemical chaperone
TUDCA [28] was able to reverse any of these events in the liver of HFru-
fed mice. Administration of TUDCA to HFru-fed mice did not affect the
levels of blood glucose, food intake or bodyweight, but normalized plas-
ma levels of insulin (Table 2). As shown in Fig. 5A, TUDCA administra-
tion abolished the increased phosphorylation of IRE1 and splicing of
XBP1 induced by HFru feeding (p b 0.05 vs. HFru). Along with the inhi-
bition of IRE1 upon TUDCA treatment, the expression of mSREBP-1c
Fig. 3. Activation of IRE1/XBP1 branch in the liver by one day of HFru diet feeding. Mice were exposed to HFru diet for one day. Protein expression of key UPR signal transducers: phos-
phorylated-IRE1, spliced XBP1, phosphorylated-eIF2α, CHOP and matured ATF6 were determined by immunoblotting of whole cell lysate from liver (A), skeletal muscle (B) and epidid-
ymal white adipose tissue (C). Representative blots are shown. Data are mean ± SE of 6–8 mice per group. * p b 0.05 compared with CH; ** p b 0.01 compared with CH.
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mice (Fig. 5B), indicating that IRE1 is a major inducer for the enhanced
hepatic DNL observed in the one day HFru-fed mice.
As TUDCA is a bile acid derivative which may be argued to affect
those pathways independent of its inhibition to the activity of IRE1,
we next administrated another IRE1 inhibitor betulin to suppress ER
stress. Betulin belongs to a class of compounds different from TUDCA,
and we found that betulin had a potent effect to inhibit IRE1 activity
(Fig. 7 A). Along with this effect, betulin also showed similar effects on
lipogenesis and abolished the impairment of hepatic insulin signaling
transduction (Fig. 7B–F).
3.6. Inhibition of IRE1 activity protected hepatic insulin signaling transduction
by diminishing JNK activity
Consistent with a reduction of the activity of IRE1, TUDCA adminis-
tration also completely abolished the activation of JNK induced by one
day feeding with HFru diet, as evidenced by the reduced phosphoryla-
tion of JNK and c-Jun (both p b 0.05 vs. HFru, Fig. 6A). This was associat-
ed with a concomitant reduction of IRS1 serine phosphorylation and
restored insulin-stimulated phosphorylation of Akt (Fig. 6B) and
GSK3β (Suppl Fig. 2) in the liver. Intriguingly, the restored hepatic insu-
lin signaling upon TUDCA treatment was found to be independent of
any changes of TG content in the liver (Fig. 6C). As membrane-associated PKCε has been demonstrated to be a key driver of impaired
insulin signaling by lipid accumulation [29,30], we hence measured
the content of membrane-associated PKCε to further assess the role of
lipid accumulation in the onset of impaired hepatic insulin signaling
transduction induced by fructose. No signiﬁcant differences were
found in the membrane-associated PKCε following one day of HFru
diet feeding compared to CH-fed mice (Fig. 6D). TUDCA treatment also
signiﬁcantly reduced microsomal TG transfer protein (MTTP, Fig. 6E),
a protein required for the hepatic TG export. Similar ﬁndings were ob-
served when IRE1 activity was blocked by betulin (Fig. 7 and Suppl
Fig. 2). Collectively, these results support the hypothesis that increased
lipid content is unlikely to be a major contributing factor to the onset of
hepatic insulin resistance induced by fructose.
4. Discussion
Thepresent study investigated themechanisms ofUPR signaling and
hepatic DNL in relation to the onset of insulin resistance in the liver. Our
data demonstrated that both UPR signaling and DNL are rapidly initiat-
ed and persisted in response to HFru feeding. Using a one day feeding
model, we found the IRE1 branch to be the ﬁrst UPR arm to be activated
in response to fructose. The activation of IRE1 was associated with im-
paired hepatic insulin signaling as indicated by reduced Akt phosphory-
lation, likely via increased JNK activity and serine phosphorylation of
Fig. 4. Impaired hepatic insulin signal transduction by one day of HFru diet feeding. Insulin signal transduction was assessed by immunoblotting of key proteins: phosphorylated-Akt
(serine 473), -JNK (Threonine 183/Tyrosine 185) and -c-Jun (serine 63) and p-IRS1 (serine 307) in whole cell lysate of liver (A), skeletal muscle (B) and epididymal white adipose tissue
(C). Representative blots are shown. Data are mean ± SE of 6–8 mice per group. * p b 0.05 compared with CH; # p b 0.05 compared with CH+ insulin.
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lin resistancewas evidenced by the fact that inhibition of IRE1 activation
by the chemical chaperone TUDCA was able to block the activation of
JNK, IRS1 serine phosphorylation and preserve the insulin-stimulated
phosphorylation of Akt and GSK3β.Table 2
Basal metabolic parameters of TUDCA treated mice.
CH HFru
Body mass (g) 24.4 ± 0.3 25.5
Caloric intake (kcal/g/day) 12.6 ± 1.9 14.0
Blood glucose (mM) 9.1 ± 1.0 9.0 ±
Plasma insulin (pg/ml) 1267 ± 131 1841
Male C57BL/6Jmicewere fed either a chow (CH) or a high fructose (HFru) diet for 1 day. The cal
for HFru diet). The animal was injected with TUDCA or vehicle four hours prior to feeding. n.d.,A growing body of evidence indicates that increased fructose intake
is an important risk factor of metabolic syndrome including type 2
diabetes [2,31,32]. It has been shown in healthy subjects that ingestion
of 20% fructose solution with meals can have higher fasting blood glu-
cose level and hepatic insulin resistance within 6 days [33]. Thus, theHFru + TUDCA HFru + Betulin
± 0.8 25.8 ± 0.5 24.3 ± 0.3
± 1.3 14.3 ± 1.2 14.8 ± 1.6
0.5 9.1 ± 0.3 9.5 ± 0.4
± 244* 1134 ± 246 n.d.
culation of caloric intakewas based on food intake (3.11 kcal/g for CHdiet and 3.569 kcal/g
not determined. Data are means ± SE of 5–10 mice per group. * p b 0.05 vs CH-fed mice.
Fig. 5. Inhibition of IRE1 activity attenuated hepatic DNL. The chemical chaperone TUDCAwas administered 4 h prior to the commencement of one day of HFru diet feeding. The activity of
IRE1 in the liverwas determinedby immunoblotting of phosphorylated-IRE1 and splicedXBP1 inwhole cell lysate (A).HepaticDNLwas assessedby immunoblotting of: ACC, FAS,matured
SREBP-1c and SCD1 (B). SREBP-1c, ACC, FAS and SCD1 were determined by immunoblots from liver tissue. Representative blots are shown. Data are mean ± SE of 6–8 mice per group. *
p b 0.05 compared with CH; # p b 0.05 compared with HFru.
Fig. 6. Inhibition of IRE1 activity by TUDCA suppressed JNK activity and protected hepatic insulin signal transduction. The chemical chaperone TUDCA was administered 4 h prior to the
commencement of one day of HFru diet feeding. The activity of JNK and insulin signal transduction was examined by immunoblotting of phosphorylated-JNK (Threonine 183/Tyrosine
185), -c-Jun (serine 63), -IRS1 (serine 307) (A) and -Akt (serine 473) (B) in whole cell lysate of liver. Hepatic triglyceride (TG) content (C). Liver membrane and cytosolic fractions
were immunoblotted for PKCε (D). Liver homogenatewas immunoblotted formicrosomal TG transfer protein (MTTP) (E). Data aremean± SE of 6–8mice per group. * p b 0.05 compared
with CH; # p b 0.05 compared with HFru.
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Fig. 7. Inhibition of IRE1 by betulin suppressed JNK activity and protected hepatic insulin signaling transduction. Mice were ﬁrst fed a chow diet mixed with betulin (30 mg kg−1
body weight) for one week and then fed a HFru diet mixed with betulin (30 mg kg−1 body weight) for 20 h. The activity of IRE1 in the liver was determined by immunoblotting of
phosphorylated-IRE1 and spliced XBP1 (A). Liver triglyceride (TG) content (B). Immunoblotting of lipogenic proteins: matured SBEBP-1c, ACC, FAS and SCD1 (C). Immunoblotting of
phosphorylated-JNK (threonine 183/tyrosine 185) (D), -IRS1 (serine 307) (E) and -Akt (serine 473) (F). Data are mean ± SE of 6–10 mice per group. * p b 0.05 compared with CH;
# p b 0.05 compared with HFru.
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by feedingmice an HFru diet mimic the onset of fructose-induced insu-
lin resistance in human. Dietary fructose is almost entirely metabolized
in the liver [34] and converted into lipids via DNL unrestrained by cellu-
lar control, because it can bypass the feedback inhibition by ATP and cit-
rate [9,35]. If unutilized, the lipids synthesized from excess DNL will be
channelled towards storage leading to hepatic steatosiswhich is consid-
ered to be closely related with insulin resistance. In addition to the po-
tent stimulation of DNL, fructose is also able to induce UPR signaling in
the liver [6].
UPR is demonstrated to contribute to insulin resistance [8,9,13] via
IRE1/XBP1 [21,36] or PERK/eIF2α [37] branch. Furthermore, it has
been suggested that UPR activation per se promotes DNL which subse-
quently leads to hepatic steatosis and impairs insulin signaling trans-
duction [8,38,39]. It has been reported that deletion of XBP1 in mice
decreased DAG, PKCε activity in the liver and protected against hepatic
insulin resistance in response to one week of fructose feeding without
suppressing JNK activation [14]. Our recent study also showed that
DAG accumulation in chronic fructose feeding associated with ER stress
and insulin resistance in the liver along with glucose intolerance [6]. As
hepatic insulin resistance is suggested to initiate whole-body insulinresistance [40], we set to investigate the involvement of cellular events
(UPR andDNL) in the development of hepatic insulin resistance induced
by HFru feeding.
In order to establish a temporal relationship among these events, we
compared the changes in PERK/elF2α and IRE1/XBP1 branches at vari-
ous durations of HFru feeding ranging from 3 days to 8 weeks. Consis-
tent with our recent ﬁnding in mice fed an HFru diets for 1 week, we
found that both PERK and IRE1 branches were activated at day 3 and
maintained throughout the entire course of the experiment. This sug-
gests that the activation of these two UPR branches was fully developed
at this early stage and impaired insulin action was detected at 1 week.
These effects sustained chronically to exert their long-term effects.
To further dissect the changes of UPR pathways at the onset of he-
patic insulin resistance, we examined the effects of one day of HFru
diet feeding on these pathways in relation to insulin signal transduction
and whole body metabolism. Interestingly, we found that one day of
HFru diet feeding is sufﬁcient to impair hepatic insulin signaling with-
out detectable glucose intolerance. The lack of glucose intolerance is ex-
plainable by the fact that at this stage insulin signaling in muscle and
adipose tissue was still intact, as indicated by the maintained Akt phos-
phorylation in response to insulin stimulation. Our ﬁndings are also
164 R.-Q. Sun et al. / Biochimica et Biophysica Acta 1852 (2015) 156–165consistent with a study in humans showing that a short-term (6 days)
ingestion of fructose results in insulin resistance in the liverwithout ob-
vious impact on insulin sensitivity in skeletal muscle [33]. Similar ﬁnd-
ings of hepatic insulin resistance prior to detectable whole-body insulin
resistance have been reported previously [41,42].
Interestingly, the DNL pathway was signiﬁcantly elevated by one
day of HFru diet feeding in the liver and this was associatedwith the ac-
tivation of only the IRE1 branch of the UPR signaling pathway, indicat-
ing that this arm rather than PERK branch may play a key role in the
onset of hepatic insulin resistance in response to fructose feeding. Al-
though IRE1/XBP1 is suggested to respond to insulin [43], mice fed an
HFru diet for 3 days or 8weeks displayed ER stress accompanied by nor-
mal plasma insulin level (Table 1). This indicated that hyperinsulinemia
was not the only trigger of IRE1 branch. IRE1 has been postulated to in-
duce insulin resistance via two distinct mechanisms. Firstly, activated
IRE1 results in the spicing of XBP1 leading to its maturation as an active
transcription factor. The spliced XBP1 can upregulate key genes of fatty
acid synthesis to increase DNL [19], leading to an accumulation of inter-
mediate lipid metabolites including diacylglycerols (DAGs) [6,8]. In-
creased DAGs in the liver can recruit protein kinase C epsilon (PKCε)
to the plasmamembranewhere it can inhibit the insulin signaling path-
ways via serine phosphorylation of insulin mediators like IRS [14,29].
This subsequently leads to decreased insulin-stimulated phosphoryla-
tion of downstream signaling effectors such as Akt resulting in insulin
resistance [44]. In the present study, we found a marked increase in
key proteins of DNL and lipid accumulation in the liver. However, our
results did not show any enrichment in the membrane-associated
PKCε following the one day of HFru diet feeding. Therefore, we exam-
ined whether or not DNL, lipid accumulation and impaired insulin sig-
naling transduction may be prevented by blocking the activation of
the IRE1/XBP1 pathway. Our results showed that the inhibition of IRE1
and the subsequent splicing of XBP1 by TUDCA completely prevented
fructose-induced DNL. This indicates the suppression of XBP1 splicing
downregulated hepatic DNL. However, PKCε was not altered in re-
sponse to decreased DNL, suggesting that the proposed DAG–PKCε
mechanism is not an initiator of insulin resistance in the liver in this
model.
The other postulatedmechanism linking IRE1 to insulin resistance is
via the activation of JNK [20,21]. It has been proposed that upon activa-
tion IRE1 recruits the adaptor protein, TNF receptor-associated factor 2
(TRAF2) to the surface of the ER membrane. The IRE1-bound TRAF2
then activates the apoptosis-signaling kinase 1 (ASK1) leading to the
phosphorylation and activation of JNK. JNK interferes with insulin sig-
naling via serine/threonine phosphorylation of IRS proteins [16] and
blunting its signal transduction to downstream molecules like Akt [45]
. Consistent with these reports, there was a marked increase in JNK ac-
tivity in the liver following one day of HFru diet feeding. As expected,
the activated JNK was found to be associated with increased serine
phosphorylation of IRS and impaired insulin signal transduction (de-
creased p-Akt in response to insulin stimulation). These data suggest
that IRE1-mediated JNK activation initiates hepatic insulin resistance
during acute HFru feeding. This mechanism is further supported by
our subsequent study showing that inhibition of IRE1with the chemical
chaperone TUDCA or betulin was able to block the activation of JNK and
serine phosphorylation of IRS1/2 and preserve insulin-stimulated phos-
phorylation of Akt andGSK3β in the liver induced by oneday of fructose
feeding.
Chronic administration of TUDCA has been reported to decrease he-
patic triglyceride levels in ob/obmice [28]. It was puzzling to us in the
ﬁrst glance that hepatic TG content was not reduced by TUDCA. Howev-
er, a recent report also shows the inability of TUDCA to reduce hepatic
steatosis [46]. One possible reason for thismight be that TUDCAwas ad-
ministered to mice in one dose only in our study. To further investigate
this discrepancy, we examined whether the lack of reduction in hepatic
TGexportmay also bedue to a simultaneous decrease in TG export from
the liver by measuring the level of MTTP, a lipid transfer proteinrequired for the assembly and secretion of VLDL-triglyceride by the
liver [47]. The decrease in liver MTTP may explain, at least in part, the
lack of change in hepatic triglyceride content in TUDCA-treated HFru-
fed mice. As the knockout of liver IRE1α has been shown to decrease
MTTP activity [48], it is likely that the down regulation of MTTPmay re-
sult from the reduced IRE1 activation by TUDCA. The protected hepatic
insulin signaling transduction by TUDCA without reducing liver TG is
consistent with our interpretation that activation of IRE1 can trigger in-
sulin resistance via the activation of JNK independently.
To further conﬁrm the effect of IRE1/JNK on impaired insulin signal-
ing transduction in the liver, we used betulin, an inhibitor of IRE1 phos-
phorylation identiﬁed by us (Fig. 7A). Despite its different chemical
structure from bile acids, the inhibition of IRE1 phosphorylation by
betulin also blocked fructose-induced phosphorylation of JNK and IRS1
(at the serine site) and reversed the impaired insulin signaling trans-
duction (indicated by the phosphorylation of Akt and GSK3β). Interest-
ingly, the activity of JNK has been found to be signiﬁcantly increased in
the liver after chronic HFru diet feeding [49]. These results together sup-
port our hypothesis that JNK activation plays an important role in lead-
ing to an impairment of insulin signaling transduction in the liver and
this may contribute to chronic insulin resistance in this organ.
In summary, the present study demonstrated that the IRE1-
mediated JNK activation, rather than lipid accumulation, is a predomi-
nant trigger for the onset of hepatic insulin resistance induced by
acute HFru feeding. However, this does not exclude the possibility that
DNL-induced lipid accumulation may contribute to the development
of hepatic insulin resistance in the long term. Our ﬁndings suggest
that the IRE1/XBP1 pathwaymay be a potential target for pharmacolog-
ical treatment of insulin resistance in the liver induced by high fructose
consumptions.
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